Overexpression of constitutively active PKG-I protects female, but not male mice from diet-induced obesity

Dejan M Nikolic1, Yanzhang Li, Shu Liu

  • 1Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Insights

Activating cyclic guanosine monophosphate (cGMP)-dependent protein kinase I (PKG-I) in female mice combats diet-induced obesity by enhancing energy expenditure and fat metabolism. Male mice showed no such protective effects, highlighting sex-specific responses.

Area of Science:

  • Molecular Biology
  • Metabolic Research
  • Obesity Studies

Background:

  • Cyclic guanosine monophosphate (cGMP)-dependent protein kinase I (PKG-I) is a key signaling molecule.
  • The role of PKG-I in regulating energy homeostasis and obesity remains largely unexplored.
  • Understanding PKG-I's function is crucial for developing novel obesity treatments.

Purpose of the Study:

  • To investigate the impact of PKG-I activation on diet-induced obesity.
  • To explore potential sex-specific differences in PKG-I's effects on metabolism.
  • To determine PKG-I's influence on adipose tissue function and energy expenditure.

Main Methods:

  • Generation of transgenic mice overexpressing constitutively active PKG-I.
  • Feeding male and female transgenic mice a low-fat or high-fat diet for 16 weeks.
  • Assessment of body weight, body fat percentage, glucose tolerance, energy expenditure, adaptive thermogenesis, and adipose tissue lipolysis.

Main Results:

  • Female transgenic mice exhibited reduced body weight gain, lower body fat, and improved glucose tolerance on a high-fat diet.
  • Male transgenic mice did not show resistance to high-fat diet-induced obesity.
  • Female transgenic mice displayed increased energy expenditure, enhanced cold-induced thermogenesis (via UCP1 in BAT), and elevated WAT lipolysis (via HSL phosphorylation).

Conclusions:

  • PKG-I activation confers protection against diet-induced obesity in female mice.
  • Sex differences exist in PKG-I's regulation of adipose tissue function and energy balance.
  • These findings suggest PKG-I as a potential therapeutic target for obesity, with considerations for sex-specific effects.